Oragenics Depreciation & Amortization 2011-2026 | OGEN

Annual Depreciation & Amortization Oragenics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	27.4 K	44.7 K	41.2 K	51.7 K	62.6 K	30.1 K	65.8 K	75 K	71.2 K	27.7 K	76.5 K	75.2 K	79.5 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
79.5 K	27.4 K	56 K

Quarterly Depreciation & Amortization Oragenics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	-	11.3 K	11.3 K	-	31.6 K	10.4 K	8.47 K	-	34.8 K	25.2 K	12.7 K	-	38.8 K	26 K	13.1 K	-	44.3 K	26.2 K	12.9 K	-	18.4 K	11 K	7.71 K	-	53.3 K	35.7 K	18 K	-	55.4 K	36.5 K	18.3 K	-	52.5 K	32.5 K	13.9 K	-	20.1 K	13.3 K	6.49 K	-	64 K	42.1 K	21 K	-	55.8 K	37.2 K	19.6 K	-	60.1 K	40.1 K	20.1 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
64 K	6.49 K	27.9 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Amphastar Pharmaceuticals AMPH	31.6 M	$ 19.44	-0.46 %	$ 909 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	1 K	-	10.36 %	$ 9.8 M	USA
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Arena Pharmaceuticals ARNA	3.87 M	-	-6.81 %	$ 3.04 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Atreca BCEL	5.46 M	-	-11.76 %	$ 5.79 M	USA
Protara Therapeutics TARA	362 K	$ 5.03	-3.08 %	$ 215 M	USA
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Tarsus Pharmaceuticals TARS	855 K	$ 67.0	-0.3 %	$ 2.8 B	USA
bluebird bio BLUE	28 M	-	-	$ 546 M	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Theravance Biopharma TBPH	1.5 M	$ 14.9	-1.91 %	$ 750 M	Cayman-islands
Avid Bioservices CDMO	11.1 M	-	-	$ 789 M	USA
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Autolus Therapeutics plc AUTL	7.55 M	$ 1.2	-6.97 %	$ 306 M	Britain
BeiGene, Ltd. BGNE	142 M	-	0.49 %	$ 251 B	Cayman-islands
Bio-Techne Corporation TECH	110 M	$ 51.31	-2.65 %	$ 8.08 B	USA
Tenax Therapeutics TENX	7.57 K	$ 14.64	-2.2 %	$ 574 M	USA
BioDelivery Sciences International BDSI	140 K	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	259 K	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	3.14 M	-	-	$ 3.74 B	USA
Enlivex Therapeutics Ltd. ENLV	546 K	$ 1.07	-2.29 %	$ 21.9 M	Israel
Teva Pharmaceutical Industries Limited TEVA	1 B	$ 28.76	-3.43 %	$ 32.9 B	Israel
Enochian Biosciences ENOB	129 K	-	-	$ 40.5 M	USA
Equillium EQ	116 K	$ 2.03	-1.46 %	$ 116 M	USA
Eton Pharmaceuticals ETON	4.04 M	$ 23.81	1.51 %	$ 641 M	USA
CRISPR Therapeutics AG CRSP	19.5 M	$ 46.38	-2.45 %	$ 4.17 B	Schweiz